Navidea Biopharmaceuticals Inc (NAVB)

[cricket69]

Navidea to Host Moderated Q&A Webcast with Management
Download as PDF
February 01, 2018
Webcast is scheduled with CFO Jed Latkin for Tuesday, February 13th at 5:00 p.m. ET
DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today that it will hold an online Question & Answer (Q&A) Session with Jed Latkin, Chief Financial and Operating Officer, and Fred Cope, Ph.D., Chief Scientific Officer of Navidea, on Tuesday February 13, 2018 at 5:00 p.m. Eastern Time. Investors are invited to submit questions they would like to hear answered to [e-mail] or [e-mail] by Friday, February 9, 2018.
From time to time, between quarterly conference calls, the management will host Q&A webcasts so investors and potential investors can learn more about the Company, its strategy, and its products.
Event:

Navidea Q&A Session – February 2018
Date:

Tuesday, February 13th, 2018
Time:

5:00 p.m. Eastern
US/Canada Toll-Free:

800-239-9838
Conference ID:

9621939
Webcast:

http://www.audio-webcast.com/cgi-bin/visitors.ssp?fn=visitor&id=5287